Medical Weight Loss
Published
May 8, 2026
3 min read
722

Why GLP-1s Are Not “Cheating” — They’re Real Medical Treatment

GLP‑1 medications restore broken hormonal pathways, reduce hunger, improve insulin sensitivity, and lower the set point — they are legitimate medical therapy.
By Dr. Nestor de la Cruz-Muñoz, MD, FACS, DABOM · Medically reviewed November 8, 2026
Open notebook with a pen resting on its pages, a closed book in the background, and a cup on a saucer on a desk.

Quick Answer

GLP‑1s are evidence‑based metabolic treatment for obesity, restoring normal physiology and treating the disease — not “cheating.”

Watch Related Video

Published Date: 
2026-11-10 13:23

Introduction

One of the most damaging myths in obesity medicine is the idea that using GLP‑1 medications — like Wegovy, Zepbound, or Saxenda — is “cheating.”

Patients hear:

  • “You should just eat less.”
  • “You’re taking the easy way out.”
  • “You don’t really want it if you need medication.”

These statements are not only wrong — they’re harmful.

They shame patients for using evidence‑based medical treatment for a real metabolic disease.

GLP‑1 medications are not shortcuts.

They are not crutches.

They are not signs of weakness.

They are legitimate, science‑based therapy for a chronic, relapsing, progressive disease that cannot be treated with willpower alone.

Let’s break down why.

1. Obesity Is a Metabolic Disease — Not a Willpower Problem

Obesity is driven by:

  • Hormones
  • Genetics
  • Gut‑brain signaling
  • Insulin resistance
  • Inflammation
  • Set‑point dysregulation

Not motivation.

Not discipline.

Not character.

GLP‑1 medications treat the biology of obesity — the same way insulin treats diabetes or inhalers treat asthma.

No one calls insulin “cheating.”

No one calls blood‑pressure medication “the easy way out.”

Obesity deserves the same respect.

2. GLP‑1s Restore a Hormonal Signal That Is Broken in Obesity

GLP‑1 is a hormone your gut naturally releases after eating.

It tells your brain:

  • “I’m full.”
  • “Stop eating.”
  • “Slow digestion.”
  • “Lower blood sugar.”

People with obesity often have blunted GLP‑1 responses, meaning:

  • They don’t feel full as quickly
  • They stay hungry longer
  • They crave more
  • They have stronger food reward pathways

GLP‑1 medications restore this signal.

This is not cheating.

This is fixing a broken pathway.

3. GLP‑1s Lower the Body’s Defended Weight (Set‑Point)

Your body has a “set‑point” — the weight it defends.

When you lose weight:

  • Hunger increases
  • Metabolism slows
  • Cravings intensify
  • Fat storage becomes more efficient

This is why dieting alone fails for most people.

GLP‑1 medications lower the set‑point, meaning:

  • Your body stops fighting weight loss
  • Hunger decreases
  • Cravings fade
  • Weight becomes easier to maintain

This is not cheating.

This is treating the root cause.

4. GLP‑1s Improve Insulin Sensitivity and Reduce Inflammation

Obesity is tightly linked to:

GLP‑1 medications:

  • Improve insulin sensitivity
  • Lower fasting insulin
  • Reduce inflammation
  • Improve liver fat
  • Stabilize blood sugar

These are medical effects, not psychological ones.

5. GLP‑1s Reduce Hunger and Cravings — They Don’t Replace Healthy Habits

Patients still need to:

  • Choose nutritious foods
  • Prioritize protein
  • Stay hydrated
  • Move their bodies
  • Build long‑term habits

GLP‑1s simply make these behaviors possible.

Patients often say:

  • “This is the first time I’ve felt in control.”
  • “I can finally stop eating when I’m full.”
  • “Food doesn’t dominate my thoughts anymore.”

That’s not cheating.

That’s normal physiology restored.

6. GLP‑1s Are Not Easy — They Require Commitment

These medications require:

  • Medical evaluation
  • Dose titration
  • Monitoring
  • Managing side effects
  • Nutrition adjustments
  • Long‑term follow‑up

Patients work hard.

They show up.

They stay engaged.

Nothing about this is “easy.”

7. GLP‑1s Are Not Cosmetic — They Improve Health

GLP‑1 medications improve:

  • Blood sugar
  • Blood pressure
  • Cholesterol
  • Liver fat
  • Inflammation
  • Sleep apnea
  • Joint pain
  • Cardiovascular risk

They reduce the risk of:

  • Heart attack
  • Stroke
  • Kidney disease
  • Diabetes progression

This is medical therapy, not vanity.

8. GLP‑1s Are Not a Replacement for Bariatric Surgery — They Are a Complement

For some patients, GLP‑1s are enough.

For others, they are a bridge to surgery.

For many, they are a long‑term metabolic support tool after surgery.

They are part of a comprehensive treatment plan, not a standalone cure.

9. The Most Important Message: You Deserve Real Treatment

If you’re using GLP‑1 medication, here’s what I want you to know:

You are not cheating.

You are not weak.

You are not taking the easy way out.

You are treating a real disease with real medicine.

You deserve the same respect as any patient managing a chronic condition.

GLP‑1s give patients their lives back — not because they replace effort, but because they make effort finally work.

Conclusion

GLP‑1 medications are one of the most important breakthroughs in obesity medicine.

They treat the biology of the disease — not the behavior.

They:

  • Reduce hunger
  • Reduce cravings
  • Improve insulin sensitivity
  • Lower the set‑point
  • Improve metabolic health
  • Support long‑term success

Using them is not cheating.

It is evidence‑based medical care for a chronic disease that deserves real treatment, real compassion, and real solutions.

Word Count: 
722
Estimated Read Time: 
3 min read

Further Information

See below for related pages.

Medical Topics Covered

This article covers the following medical topics and related areas.
Dr. Nestor de la Cruz-Munoz wearing a white lab coat with 'N. de la Cruz-Munoz MD Metabolic Surgery'  standing outdoors by a waterfront with buildings and boats in the background under a clear sky.
A black and white icon of a globe with two circular arrows surrounding it, symbolizing global recycling or environmental sustainability.
Nestor de la Cruz-Muñoz, MD, FACS, DABOM
About the Author
Nestor de la Cruz‑Muñoz, MD, FACS, DABOM
‍Dr. Nestor de la Cruz‑Muñoz is a nationally recognized bariatric, metabolic, and foregut surgeon with over 25 years of experience, more than 9,000 bariatric operations and over 15,000 minimally invasive procedures, treating complex obesity‑related and gastrointestinal conditions. He serves as the Medical Director of Bariatric and Metabolic Surgery at HCA Florida Mercy Hospital and has held academic appointments as a Professor of Surgery at a major university‑based medical center.

Dr. de la Cruz‑Muñoz specializes in advanced minimally invasive and robotic surgery, metabolic disease management, and comprehensive long‑term patient care. His work integrates clinical expertise, academic leadership, and a commitment to evidence‑based medicine. He has trained surgeons across the country, contributed to national guidelines, and is widely regarded for his outcomes, innovation, and patient‑centered approach.

Patients choose Dr. de la Cruz‑Muñoz for his combination of surgical excellence, metabolic expertise, and lifelong dedication to improving patient health through compassionate, high‑quality care.
Book Now
Close-up of a stethoscope, clipboard, and pen on a white surface, suggesting a medical or healthcare setting.

Contact Details

Black cross or x symbol on a transparent or white background, commonly used as a close button or cancel icon.